
  
    
      
        Background_NNP
        Since_IN the_NNP '_POS seed_NN and_CC soil_NN '_'' hypothesis_NNS of_IN Paget_NNP in_IN the_DT
        19_CD th_NN century_NN [_NN 1_CD ]_NN ,_, it_PRP has_VBZ been_VBN understood_VBN that_IN the_DT
        microenvironment_NN ,_, or_CC '_POS soil_NN ,_, '_'' surrounding_VBG the_DT tumor_NN '_'' seed_NN '_''
        plays_VBZ a_DT critical_JJ part_NN in_IN its_PRP$ development_NN ._. However_RB ,_,
        investigations_NNS into_IN the_DT molecular_JJ biology_NN of_IN cancers_NNS are_VBP
        often_RB carried_VBN out_IN on_IN cells_NNS grown_VBN 
        in_IN vitro_NN in_IN culture_NN ,_, where_WRB the_DT
        environment_NN is_VBZ unlike_IN that_DT of_IN the_DT 
        in_IN vivo_NN tissue_NN environment_NN in_IN which_WDT
        cancers_NNS naturally_RB develop_VBP ._. The_DT effects_NNS of_IN these_DT
        environmental_JJ differences_NNS on_IN cancer_NN cells_NNS may_MD account_VB ,_, in_IN
        part_NN ,_, for_IN the_DT fact_NN that_IN only_RB a_DT small_JJ percentage_NN of_IN
        anticancer_NN drugs_NNS that_WDT are_VBP found_VBN to_TO effectively_RB kill_VB cells_NNS 
        in_IN vitro_NN are_VBP successful_JJ in_IN subsequent_JJ
        animal_NN and_CC human_JJ studies_NNS ._. In_IN this_DT study_NN ,_, we_PRP explored_JJ the_DT
        changes_NNS that_WDT occur_VBP at_IN the_DT transcriptome_NN level_NN as_IN cells_NNS
        grown_VBN 
        in_IN vitro_NN are_VBP transplanted_VBN into_IN an_DT 
        in_IN vivo_NN environment_NN ,_, where_WRB they_PRP
        develop_VBP as_IN a_DT tumor_NN ._. The_DT 
        in_IN vivo_NN environment_NN represented_VBD here_RB
        is_VBZ that_IN of_IN the_DT subcutaneous_JJ intrascapular_NN region_NN of_IN the_DT
        nude_JJ mouse_NN ._. Two_CD different_JJ cell_NN lines_NNS were_VBD studied_VBN :_: A_DT 549_CD ,_,
        derived_VBN from_IN human_JJ lung_NN adenocarcinoma_NN ,_, and_CC U_NNP 118_CD ,_, derived_VBN
        from_IN human_JJ brain_NN glioblastoma_NN ._. Our_PRP$ study_NN examined_VBD the_DT
        differences_NNS in_IN global_JJ gene_NN expression_NN between_IN A_DT 549_CD mouse_NN
        xenograft_NN tumors_NNS and_CC A_DT 549_CD cell_NN cultures_NNS and_CC between_IN U_NNP 118_CD
        xenograft_NN tumors_NNS (_( grown_VBN in_IN the_DT same_JJ location_NN as_IN the_DT A_DT 549_CD
        tumors_NNS )_) and_CC U_NNP 118_CD cultures_NNS ._. We_PRP looked_VBD for_IN 
        in_IN vivo_NN versus_CC 
        in_IN vitro_NN differences_NNS that_WDT were_VBD common_JJ
        to_TO the_DT two_CD cell_NN lines_NNS ,_, and_CC for_IN differences_NNS that_WDT were_VBD found_VBN
        in_IN one_CD cell_NN line_NN but_CC not_RB the_DT other_JJ ._.
        In_IN modeling_NN mechanisms_NNS of_IN cancer_NN development_NN ,_, global_JJ
        gene-expression_JJ profiling_VBG of_IN human-derived_JJ cells_NNS grown_VBN as_IN
        tumors_NNS in_IN mice_NNS has_VBZ some_DT distinct_JJ advantages_NNS over_IN profiling_VBG
        of_IN tumors_NNS obtained_VBN from_IN patients_NNS ._. Whereas_IN a_DT great_JJ deal_NN of_IN
        genetic_JJ variability_NN exists_VBZ among_IN different_JJ tumors_NNS from_IN
        different_JJ patients_NNS ,_, lesser_JJR genetic_JJ heterogeneity_NN would_MD be_VB
        expected_VBN in_IN xenografts_NNS of_IN cancer_NN cells_NNS originally_RB derived_VBN
        from_IN a_DT single_JJ patient_NN ._. Furthermore_RB ,_, patient-derived_JJ tumors_NNS
        are_VBP composed_VBN of_IN both_DT cancer_NN and_CC non-cancer_JJ cells_NNS ,_, making_VBG it_PRP
        difficult_JJ to_TO precisely_RB ascertain_VB gene-expression_JJ patterns_NNS
        specifically_RB attributable_JJ to_TO cancer_NN cells_NNS ._. For_IN example_NN ,_, in_IN
        many_JJ cancer_NN microarray_NN studies_NNS ,_, the_DT actual_JJ percentage_NN of_IN
        cancer_NN cells_NNS in_IN a_DT profiled_VBN sample_NN may_MD be_VB as_RB low_JJ as_IN 30_CD -_: 40_CD %_NN [_NN
        2_CD ]_NN ._. Even_RB when_WRB using_VBG techniques_NNS such_JJ as_IN laser_NN capture_NN
        microdissection_NN ,_, which_WDT can_MD improve_VB tumor_NN purity_NN [_NN 3_CD ]_NN ,_, the_DT
        relative_JJ contribution_NN of_IN cancer_NN cells_NNS and_CC non-cancer_JJ cells_NNS
        to_TO the_DT overall_JJ gene-expression_JJ profile_NN remains_VBZ uncertain_JJ ._.
        In_IN contrast_NN ,_, profiling_VBG human_JJ genes_NNS expressed_VBD in_IN a_DT mouse_NN
        xenograft_NN using_VBG a_DT human_JJ microarray_NN chip_NN might_MD uncover_VB genes_NNS
        specifically_RB expressed_VBD in_IN human_JJ cancer_NN cells_NNS in_IN xenograft_NN
        tumors_NNS comprised_VBN of_IN a_DT mixture_NN of_IN human-_NN and_CC mouse-derived_JJ
        cells_NNS [_NN 4_CD ]_NN ._.
        The_DT data_NNS obtained_VBN in_IN a_DT microarray_NN experiment_NN can_MD be_VB
        overwhelming_JJ ,_, and_CC the_DT challenge_NN is_VBZ to_TO understand_VB ,_, on_IN a_DT
        global_JJ systems_NNS level_NN ,_, the_DT biology_NN behind_IN the_DT differences_NNS in_IN
        expression_NN observed_VBD in_IN hundreds_NNS of_IN genes_NNS ._. In_IN this_DT study_NN ,_, we_PRP
        have_VBP searched_VBD for_IN '_POS significantly_RB enriched_JJ '_POS classes_NNS of_IN genes_NNS
        among_IN all_DT differentially_RB expressed_VBN genes_NNS ._. These_DT are_VBP classes_NNS
        or_CC functional_JJ categories_NNS of_IN genes_NNS that_WDT appear_VBP
        overrepresented_JJ in_IN the_DT set_NN of_IN differentially_RB expressed_VBD
        genes_NNS ._. As_IN a_DT result_NN ,_, valuable_JJ clues_NNS could_MD emerge_VB as_IN to_TO the_DT
        dominant_JJ biological_JJ features_NNS or_CC processes_VBZ that_WDT might_MD
        underlie_VB the_DT coordinate_VB expression_NN of_IN these_DT genes_NNS ._. Such_JJ
        clues_NNS could_MD be_VB especially_RB convincing_JJ if_IN it_PRP can_MD be_VB shown_VBN
        that_IN the_DT enriched_JJ classes_NNS are_VBP unlikely_JJ to_TO represent_VB a_DT
        chance_NN occurrence_NN ._. Gene_NNP classes_NNS can_MD be_VB defined_VBN by_IN common_JJ
        gene_NN annotations_NNS or_CC concepts_NNS from_IN the_DT biomedical_JJ
        literature_NN ._.
      
      
        Results_NNS
        
          Global_JJ differences_NNS in_IN gene_NN expression_NN between_IN
          xenograft_NN tumors_NNS and_CC cell_NN cultures_NNS
          A_DT 549_CD and_CC U_NNP 118_CD cells_NNS were_VBD each_DT transplanted_VBN
          subcutaneously_RB into_IN the_DT intrascapular_NN region_NN of_IN
          immunodeficient_NN mice_NNS ,_, within_IN which_WDT sizable_JJ tumors_NNS
          developed_VBN after_IN 21_CD days_NNS ._. Global_JJ mRNA_NN expression_NN profiles_NNS
          from_IN these_DT tumors_NNS ,_, using_VBG Affymetrix_NNP HuGeneFL_NNP chips_NNS ,_, were_VBD
          compared_VBN with_IN profiles_NNS obtained_VBN from_IN the_DT cell_NN lines_NNS as_IN
          grown_VBN in_IN culture_NN ._. Between_IN the_DT A_DT 549_CD xenograft_NN tumors_NNS and_CC
          the_DT A_DT 549_CD cell_NN cultures_NNS ,_, 357_CD genes_NNS (_( 375_CD probe_NN sets_NNS )_)
          differed_VBD significantly_RB at_IN 
          p_NN <_NN 0_CD ._. 01_CD with_IN a_DT fold_VB change_NN
          greater_JJR than_IN two_CD either_DT way_NN (_( 134_CD genes_NNS being_VBG higher_JJR in_IN
          tumors_NNS and_CC 223_CD genes_NNS being_VBG higher_JJR in_IN culture_NN )_) ,_, a_DT number_NN
          much_RB greater_JJR than_IN the_DT 24_CD to_TO be_VB expected_VBN by_IN chance_NN ,_, as_IN
          determined_VBN by_IN permutation_NN testing_NN ._. Between_IN the_DT U_NNP 118_CD
          xenograft_NN tumors_NNS and_CC cell_NN cultures_NNS ,_, 368_CD genes_NNS (_( 387_CD probe_NN
          sets_NNS )_) differed_VBD significantly_RB (_( 112_CD genes_NNS being_VBG higher_JJR in_IN
          tumors_NNS and_CC 256_CD genes_NNS being_VBG higher_JJR in_IN culture_NN )_) ,_, with_IN 29_CD
          expected_VBN false_JJ positives_NNS due_JJ to_TO chance_NN ._. Table_NNP 1_CD shows_VBZ the_DT
          genes_NNS with_IN highest_JJS expression_NN in_IN tumors_NNS compared_VBN with_IN
          cultures_NNS ,_, for_IN each_DT of_IN the_DT cell_NN lines_NNS ._.
          From_IN histological_JJ analysis_NN the_DT amount_NN of_IN mouse_NN tissue_NN
          in_IN a_DT xenograft_NN tumor_NN was_VBD estimated_VBN between_IN 10_CD and_CC 20_CD %_NN ._. To_TO
          determine_VB the_DT extent_NN of_IN hybridization_NN with_IN the_DT human_JJ
          HuGeneFL_NNP chip_NN that_WDT might_MD be_VB attributable_JJ to_TO mouse_NN RNA_NNP ,_, a_DT
          sample_NN of_IN mouse_NN lung_NN tissue_NN was_VBD also_RB profiled_VBN ._. Whereas_IN
          the_DT total_JJ amount_NN of_IN hybridization_NN measured_VBN in_IN the_DT
          xenograft_NN tumor_NN profiles_NNS was_VBD comparable_JJ to_TO that_DT of_IN the_DT
          culture_NN profiles_NNS with_IN equal_JJ amounts_NNS of_IN RNA_NNP ,_, the_DT total_JJ
          hybridization_NN measured_VBN in_IN the_DT mouse_NN control_NN profile_NN was_VBD
          found_VBN to_TO be_VB about_IN one-fifth_NN that_IN of_IN a_DT xenograft_NN profile_NN ,_,
          with_IN the_DT same_JJ amount_NN of_IN RNA_NNP ._. As_IN the_DT control_NN profile_NN was_VBD
          from_IN a_DT sample_NN of_IN 100_CD %_NN mouse_NN tissue_NN ,_, the_DT contribution_NN of_IN
          mouse_NN genes_NNS to_TO differences_NNS observed_VBD in_IN gene_NN expression_NN
          between_IN cell_NN cultures_NNS and_CC tumors_NNS was_VBD considered_VBN to_TO be_VB
          minimal_JJ ._. From_IN a_DT comparison_NN of_IN the_DT individual_JJ probe-set_JJ
          intensities_NNS of_IN the_DT mouse_NN lung_NN profile_NN with_IN those_DT of_IN the_DT
          culture_NN profiles_NNS ,_, and_CC assuming_VBG a_DT 20_CD %_NN contribution_NN of_IN
          mouse_NN tissue_NN to_TO the_DT human_JJ xenograft_NN sample_NN ,_, we_PRP estimate_VBP
          that_IN in_IN only_RB about_IN 20_CD out_IN of_IN the_DT 7_CD ,_, 069_CD probe_NN sets_NNS on_IN the_DT
          HuGeneFL_NNP chip_NN (_( a_DT number_NN on_IN the_DT level_NN of_IN measurement_NN noise_NN
          in_IN a_DT microarray_NN experiment_NN )_) would_MD the_DT amount_NN of_IN
          hybridization_NN from_IN mouse_NN tissue_NN alone_RB have_VBP been_VBN high_JJ
          enough_RB to_TO account_VB for_IN greater_JJR than_IN twofold_NN changes_NNS
          between_IN cell_NN cultures_NNS and_CC tumors_NNS ._. In_IN contrast_NN ,_, nearly_RB 800_CD
          probe_NN sets_NNS showed_VBD a_DT greater_JJR than_IN twofold_NN increase_NN on_IN
          average_JJ from_IN A_DT 549_CD culture_NN profiles_NNS to_TO A_DT 549_CD xenograft_NN
          tumor_NN profiles_NNS ._. It_PRP can_MD therefore_RB be_VB concluded_VBN that_IN ,_, in_IN
          all_DT but_CC a_DT handful_NN of_IN genes_NNS ,_, the_DT numerous_JJ significant_JJ
          changes_NNS observed_VBD in_IN gene_NN expression_NN in_IN the_DT xenograft_NN
          tumors_NNS are_VBP due_JJ to_TO the_DT cancerous_JJ (_( human_JJ )_) cells_NNS and_CC not_RB the_DT
          surrounding_VBG (_( mouse_NN )_) host_NN tissue_NN ._.
          Principal_NN components_NNS were_VBD extracted_VBN from_IN the_DT cell_NN
          culture_NN and_CC xenograft_NN expression_NN data_NNS using_VBG all_DT 7_CD ,_, 069_CD
          probe_NN sets_NNS considered_VBN in_IN the_DT analysis_NN ._. The_DT first_JJ
          principal_JJ component_NN captures_NNS the_DT greatest_JJS fraction_NN of_IN the_DT
          overall_JJ variance_NN in_IN gene_NN expression_NN ;_: the_DT second_JJ captures_NNS
          the_DT greatest_JJS fraction_NN of_IN variance_NN subject_JJ to_TO being_VBG
          independent_JJ of_IN the_DT first_JJ ,_, and_CC so_RB on_IN ._. From_IN the_DT first_JJ two_CD
          principal_JJ components_NNS ,_, a_DT pair_NN of_IN coordinates_VBZ was_VBD
          determined_VBN for_IN each_DT xenograft_NN and_CC cell_NN culture_NN profile_NN to_TO
          construct_VB a_DT two-dimensional_JJ view_NN that_WDT reflects_VBZ the_DT
          relative_JJ locations_NNS of_IN the_DT profiles_NNS in_IN the_DT
          higher-dimensional_JJ space_NN ._. On_IN the_DT same_JJ two-dimensional_JJ
          view_NN ,_, we_PRP plotted_VBD one_CD dataset_NN of_IN 86_CD profiles_NNS from_IN lung_NN
          adenocarcinomas_NNS and_CC another_DT dataset_NN of_IN 45_CD profiles_NNS from_IN
          glioblastomas_NNS and_CC astrocytomas_NNS ,_, generated_VBN from_IN previous_JJ
          global_JJ gene-expression_JJ studies_NNS [_NN 5_CD 6_CD ]_NN ._. Figure_NN 1_CD shows_VBZ
          this_DT principal_JJ components_NNS analysis_NN (_( PCA_NNP )_) plot_NN of_IN the_DT
          gene-expression_JJ profiles_NNS from_IN cell_NN cultures_NNS ,_, xenografts_NNS ,_,
          and_CC human_JJ lung_NN and_CC brain_NN tumors_NNS ._. Although_IN none_NN of_IN the_DT
          human_JJ tumor_NN profiles_NNS was_VBD used_VBN to_TO define_VB the_DT principal_JJ
          components_NNS coordinate_VB space_NN ,_, lung_NN tumor_NN profiles_NNS appear_VBP
          well_RB separated_JJ on_IN the_DT plot_NN from_IN brain_NN tumor_NN profiles_NNS ._.
          A_DT 549_CD profiles_NNS (_( both_DT xenograft_NN and_CC culture_NN )_) are_VBP grouped_VBN
          with_IN lung_NN tumors_NNS rather_RB than_IN brain_NN tumors_NNS ,_, and_CC U_NNP 118_CD
          profiles_NNS ,_, with_IN brain_NN tumors_NNS rather_RB than_IN lung_NN tumors_NNS ._. Of_IN
          the_DT 134_CD genes_NNS found_VBD expressed_VBN more_RBR highly_RB in_IN A_DT 549_CD
          xenograft_NN tumors_NNS over_IN A_DT 549_CD cultures_NNS (_( 
          p_NN <_NN 0_CD ._. 01_CD ,_, fold_VBP change_NN >_NN 2_LS )_) ,_,
          70_CD were_VBD also_RB higher_JJR in_IN stage_NN I_PRP adenocarcinomas_NNS over_IN A_DT 549_CD
          cultures_NNS (_( 
          p_NN <_NN 0_CD ._. 05_CD )_) ._. Of_IN the_DT 112_CD genes_NNS
          upregulated_JJ in_IN U_NNP 118_CD xenograft_NN tumors_NNS over_IN cultures_NNS ,_, 50_CD
          were_VBD also_RB higher_JJR in_IN high-grade_JJ glioblastomas_NNS over_IN U_NNP 118_CD
          cultures_NNS (_( 
          p_NN <_NN 0_CD ._. 05_CD )_) ._.
        
        
          Overrepresentation_NNP of_IN genes_NNS involved_VBN in_IN cell_NN
          division_NN and_CC metabolism_NN among_IN genes_NNS upregulated_JJ in_IN cancer_NN
          cells_NNS in_IN culture_NN relative_JJ to_TO xenografts_NNS
          Searches_NNP were_VBD made_VBN for_IN significantly_RB enriched_JJ gene_NN
          classes_NNS ,_, as_IN defined_VBN by_IN Gene_NNP Ontology_NNP (_( GO_NNP )_) annotation_NN or_CC
          Medical_NNP Subject_NNP Heading_VBG Index_NNP (_( MeSH_NNP )_) term_NN association_NN
          (_( see_VB Materials_NNPS and_CC methods_NNS )_) ,_, for_IN both_DT the_DT set_NN of_IN 223_CD
          genes_NNS upregulated_JJ in_IN the_DT A_DT 549_CD cell_NN cultures_NNS over_IN A_DT 549_CD
          tumors_NNS and_CC the_DT set_NN of_IN 256_CD genes_NNS upregulated_JJ in_IN the_DT U_NNP 118_CD
          cell_NN cultures_NNS over_IN the_DT U_NNP 118_CD tumors_NNS (_( 
          p_NN <_NN 0_CD ._. 01_CD ,_, fold_VBP change_NN >_NN 2_LS )_) ._.
          In_IN each_DT case_NN ,_, the_DT 
          p_NN -_: values_NNS for_IN the_DT most_RBS enriched_JJ
          classes_NNS appeared_VBD highly_RB significant_JJ compared_VBN to_TO what_WP
          would_MD be_VB expected_VBN ,_, based_VBN on_IN simulation_NN results_NNS ,_, in_IN a_DT
          randomly_RB selected_VBN set_NN of_IN the_DT same_JJ number_NN of_IN genes_NNS ._. For_IN
          example_NN ,_, for_IN the_DT A_DT 549_CD set_NN of_IN 223_CD genes_NNS ,_, 35_CD enriched_JJ
          LocusLink_NNP annotation_NN terms_NNS were_VBD found_VBN that_WDT had_VBD a_DT 
          p_NN -_: value_NN less_JJR than_IN 1_CD ._. 9_CD E-_NNP 03_CD ,_, where_WRB
          one_CD term_NN with_IN a_DT 
          p_NN -_: value_NN less_JJR than_IN 1_CD ._. 9_CD E-_NNP 03_CD would_MD be_VB
          expected_VBN in_IN a_DT given_VBN set_NN of_IN 223_CD randomly_RB selected_VBN genes_NNS ._.
          Out_IN of_IN 100_CD simulation_NN tests_NNS ,_, no_DT single_JJ test_NN had_VBD more_JJR than_IN
          eight_CD terms_NNS with_IN a_DT 
          p_NN -_: value_NN less_JJR than_IN 1_CD ._. 9_CD E-_NNP 03_CD ._. Table_NNP
          2_CD shows_VBZ the_DT top_JJ gene_NN classes_NNS found_VBD in_IN both_DT the_DT A_DT 549_CD set_VBN
          and_CC the_DT U_NNP 118_CD set_VBN with_IN 
          p_NN -_: values_NNS less_JJR than_IN 0_CD ._. 05_CD ._. There_EX are_VBP
          far_RB more_JJR gene_NN classes_NNS common_JJ to_TO both_DT gene_NN sets_NNS with_IN 
          p_NN <_NN 0_CD ._. 05_CD in_IN each_DT than_IN would_MD be_VB
          expected_VBN in_IN two_CD randomly_RB selected_VBN gene_NN sets_NNS of_IN 223_CD and_CC
          256_CD (_( for_IN example_NN ,_, for_IN the_DT MeSH_NNP term_NN classes_NNS ,_, 37_CD were_VBD
          found_VBN to_TO be_VB significantly_RB enriched_JJ in_IN the_DT actual_JJ data_NN ,_,
          whereas_IN about_IN two_CD would_MD be_VB expected_VBN to_TO occur_VB by_IN chance_NN ,_,
          see_VB Table_NNP 2_LS )_) ._.
          Taken_VBN together_RB ,_, the_DT significantly_RB enriched_JJ classes_NNS
          found_VBD for_IN both_DT the_DT A_DT 549_CD and_CC the_DT U_NNP 118_CD genes_NNS in_IN cell_NN
          culture_NN compared_VBN with_IN tumors_NNS are_VBP highly_RB indicative_JJ of_IN
          processes_NNS of_IN cell_NN division_NN and_CC metabolism_NN ,_, with_IN
          significant_JJ MeSH_NNP term_NN classes_NNS for_IN the_DT two_CD gene_NN sets_VBZ
          including_VBG '_POS Cell_NNP cycle_NN '_'' (_( 62_CD genes_NNS for_IN A_DT 549_CD ,_, 66_CD genes_NNS for_IN
          U_NNP 118_CD )_) ,_, '_'' DNA_NNP replication_NN '_'' (_( 30_CD ,_, 33_CD )_) ,_, '_'' Mitosis_NNP '_POS (_( 28_CD ,_, 37_CD )_) ,_,
          '_'' Mitochondria_NNP '_POS (_( 38_CD ,_, 52_CD )_) ,_, and_CC '_POS Cyclin-dependent_NNP kinases_NNS '_POS
          (_( 21_CD ,_, 30_CD )_) ;_: and_CC significant_JJ GO_NNP terms_NNS including_VBG '_POS Cell_NNP
          proliferation_NN '_'' (_( 36_CD ,_, 39_CD )_) ,_, '_'' Metabolism_NNP '_POS (_( 108_CD ,_, 134_CD )_) ,_,
          '_'' Cytokinesis_NNP '_POS (_( 8_CD ,_, 6_CD )_) ,_, '_'' Tricarboxylic_NNP acid_NN cycle_NN '_'' (_( 3_CD ,_, 5_LS )_) ,_,
          and_CC '_POS G_NNP 1_CD /_NN S_NNP transition_NN '_'' (_( 5_CD ,_, 7_CD )_) ._. A_DT search_NN for_IN enriched_JJ gene_NN
          classes_NNS was_VBD also_RB made_VBN for_IN 157_CD genes_NNS that_WDT were_VBD expressed_VBN
          more_RBR highly_RB (_( 
          p_NN <_NN 0_CD ._. 05_CD ,_, fold_VBP change_NN >_NN 2_LS )_) in_IN
          both_DT A_DT 549_CD and_CC U_NNP 118_CD cell_NN cultures_NNS over_IN tumors_NNS ,_, and_CC the_DT
          significant_JJ classes_NNS found_VBD were_VBD the_DT same_JJ ,_, or_CC of_IN the_DT same_JJ
          nature_NN ,_, as_IN the_DT classes_NNS listed_VBN in_IN Table_NNP 2_CD ._. For_IN the_DT entire_JJ
          set_NN of_IN enriched_JJ classes_NNS for_IN genes_NNS upregulated_JJ in_IN cell_NN
          cultures_NNS over_IN the_DT xenograft_NN tumors_NNS ,_, including_VBG which_WDT genes_NNS
          belong_VBP to_TO which_WDT classes_NNS ,_, see_VB Additional_JJ data_NNS files_NNS and_CC [_NN
          7_CD ]_NN ._.
        
        
          Overrepresentation_NNP of_IN genes_NNS involved_VBN in_IN cell_NN
          adhesion_NN ,_, the_DT extracellular_NN matrix_NN ,_, and_CC vascularization_NN
          among_IN genes_NNS upregulated_JJ in_IN cancer_NN cells_NNS in_IN xenografts_NNS
          relative_JJ to_TO cultures_NNS
          As_IN with_IN the_DT genes_NNS expressed_VBD at_IN higher_JJR levels_NNS in_IN
          culture_NN compared_VBN to_TO xenografts_NNS ,_, searches_NNS were_VBD made_VBN for_IN
          significantly_RB enriched_JJ GO_NNP and_CC MeSH_NNP term_NN classes_NNS for_IN the_DT
          set_NN of_IN 134_CD genes_NNS with_IN significantly_RB higher_JJR expression_NN (_( 
          p_NN <_NN 0_CD ._. 01_CD ,_, fold_VBP change_NN >_NN 2_LS )_) in_IN
          the_DT A_DT 549_CD tumors_NNS over_IN the_DT A_DT 549_CD cell_NN cultures_NNS and_CC the_DT set_NN
          of_IN 112_CD genes_NNS upregulated_JJ in_IN the_DT U_NNP 118_CD tumors_NNS over_IN the_DT U_NNP 118_CD
          cell_NN cultures_NNS ._. Again_RB ,_, in_IN each_DT case_NN ,_, the_DT 
          p_NN -_: values_NNS for_IN the_DT most_RBS enriched_JJ
          classes_NNS found_VBD were_VBD quite_RB significant_JJ over_IN what_WP would_MD be_VB
          expected_VBN by_IN chance_NN ._. For_IN example_NN ,_, for_IN the_DT A_DT 549_CD set_NN of_IN 134_CD
          genes_NNS ,_, 36_CD enriched_JJ MeSH_NNP terms_NNS were_VBD found_VBN that_WDT had_VBD a_DT 
          p_NN -_: value_NN less_JJR than_IN 7_CD E-_NNP 04_CD ,_, where_WRB one_CD
          term_NN would_MD be_VB expected_VBN to_TO have_VB 
          p_NN less_JJR than_IN 7_CD E-_NNP 04_CD in_IN a_DT set_NN of_IN 134_CD
          randomly_RB selected_VBN genes_NNS ;_: out_IN of_IN 100_CD simulation_NN tests_NNS ,_, no_DT
          single_JJ test_NN had_VBD more_JJR than_IN six_CD terms_NNS with_IN a_DT 
          p_NN -_: value_NN less_JJR than_IN 7_CD E-_NNP 04_CD ._. Table_NNP
          3_CD shows_VBZ the_DT top_JJ gene_NN classes_NNS found_VBD in_IN both_DT the_DT A_DT 549_CD set_VBN
          and_CC the_DT U_NNP 118_CD set_VBN with_IN 
          p_NN -_: values_NNS less_JJR than_IN 0_CD ._. 05_CD ._.
          Taken_VBN together_RB ,_, the_DT significantly_RB enriched_JJ gene_NN
          classes_NNS for_IN A_DT 549_CD and_CC U_NNP 118_CD genes_NNS that_WDT were_VBD upregulated_JJ in_IN
          tumors_NNS compared_VBN to_TO cell_NN culture_NN are_VBP highly_RB indicative_JJ of_IN
          processes_NNS involving_VBG cell_NN adhesion_NN and_CC the_DT extracellular_NN
          matrix_NN (_( ECM_NNP )_) ._. Significant_JJ MeSH_NNP term_NN classes_NNS for_IN the_DT two_CD
          gene_NN sets_VBZ included_VBD '_POS Cell_NNP adhesion_NN '_'' (_( 26_CD genes_NNS for_IN A_DT 549_CD ,_, 21_CD
          genes_NNS for_IN U_NNP 118_CD )_) ,_, '_'' Extracellular_NNP matrix_NN proteins_NNS '_POS (_( 15_CD ,_, 16_CD )_) ,_,
          '_'' Cytokines_NNP '_POS (_( 28_CD ,_, 26_CD )_) ,_, '_'' Collagen_NNP '_POS (_( 28_CD ,_, 33_CD )_) ,_, '_'' Fibroblasts_NNP '_POS
          (_( 40_CD ,_, 35_CD )_) ,_, '_'' Metalloendopeptidases_NNP '_POS (_( 11_CD ,_, 12_CD )_) ,_, '_'' Growth_NNP
          Substances_NNP '_POS (_( 14_CD ,_, 16_CD )_) ,_, '_'' Proteoglycans_NNP '_POS (_( 11_CD ,_, 15_CD )_) ,_, and_CC
          '_POS Transcription_NNP factor_NN Sp_NNP 1_CD '_POS (_( 11_CD ,_, 10_CD )_) ._. Sp_NNP 1_CD is_VBZ important_JJ for_IN
          the_DT basal_NN expression_NN of_IN various_JJ collagens_NNS ,_, and_CC blocking_VBG
          Sp_NNP 1_CD broadly_RB inhibits_NNS expression_NN of_IN ECM_NNP genes_NNS [_NN 8_CD ]_NN ._.
          Terms_NNS such_JJ as_IN '_POS Pathologic_NNP neovascularization_NN '_'' (_( 13_CD ,_, 9_CD )_) and_CC
          '_POS Vascular_NNP endothelium_NN '_'' (_( 29_CD ,_, 26_CD )_) can_MD refer_VB to_TO processes_NNS of_IN
          angiogenesis_NNS ,_, the_DT generation_NN of_IN new_JJ blood_NN vessels_NNS from_IN
          preexisting_VBG vessels_NNS for_IN the_DT delivery_NN of_IN nutrients_NNS to_TO
          tumors_NNS ._. Other_JJ disease-related_JJ terms_NNS include_VBP '_POS Precancerous_NNP
          conditions_NNS '_POS (_( 11_CD ,_, 8_CD )_) ,_, '_'' Pulmonary_NNP fibrosis_NNS '_POS (_( 5_CD ,_, 5_CD ;_: a_DT
          condition_NN involving_VBG chronic_JJ inflammation_NN and_CC progressive_JJ
          fibrosis_NNS of_IN the_DT pulmonary_JJ alveolar_NN walls_NNS )_) ,_, and_CC '_POS Systemic_NNP
          scleroderma_NN '_'' (_( 4_CD ,_, 6_CD ;_: characterized_VBN by_IN hardening_VBG of_IN affected_VBN
          tissues_NNS )_) ._. Also_RB of_IN interest_NN is_VBZ the_DT significant_JJ term_NN '_'' Stem_NNP
          cells_NNS '_POS (_( 23_CD ,_, 20_CD )_) ,_, as_IN similar_JJ signaling_VBG pathways_NNS are_VBP thought_VBN
          to_TO regulate_VB self-renewal_JJ in_IN stem_NN cells_NNS and_CC cancer_NN cells_NNS ,_,
          and_CC as_IN tumors_NNS may_MD include_VB stem_VB cells_NNS [_NN 9_CD ]_NN ._. The_DT entire_JJ
          set_NN of_IN enriched_JJ classes_NNS found_VBD for_IN genes_NNS expressed_VBD more_RBR
          strongly_RB in_IN the_DT xenografts_NNS over_IN the_DT cell_NN cultures_NNS ,_,
          including_VBG which_WDT genes_NNS belong_VBP to_TO which_WDT classes_NNS ,_, is_VBZ
          available_JJ as_IN additional_JJ data_NNS files_NNS and_CC from_IN [_NN 7_CD ]_NN ._.
        
        
          Upregulation_NNP of_IN genes_NNS specific_JJ to_TO cell-line_JJ lineage_NN
          in_IN xenografts_NNS
          While_IN several_JJ gene_NN classes_NNS were_VBD found_VBN in_IN common_JJ
          between_IN the_DT 112_CD genes_NNS upregulated_JJ in_IN U_NNP 118_CD tumors_NNS and_CC the_DT
          134_CD genes_NNS upregulated_JJ in_IN A_DT 549_CD tumors_NNS over_IN cultures_NNS (_( 
          p_NN <_NN 0_CD ._. 01_CD ,_, fold_VBP change_NN >_NN 2_LS )_) ,_,
          only_RB 10_CD upregulated_JJ genes_NNS were_VBD shared_VBN between_IN the_DT two_CD
          gene_NN sets_NNS ._. At_IN a_DT significance_NN level_NN of_IN 0_CD ._. 05_CD ,_, 26_CD genes_NNS were_VBD
          shared_VBN between_IN the_DT 301_CD genes_NNS upregulated_JJ in_IN U_NNP 118_CD tumors_NNS
          and_CC the_DT 229_CD genes_NNS upregulated_JJ in_IN A_DT 549_CD tumors_NNS over_IN
          cultures_NNS ,_, whereas_IN 12_CD would_MD be_VB expected_VBN if_IN the_DT two_CD gene_NN
          sets_NNS were_VBD independent_JJ of_IN each_DT other_JJ ._. By_IN comparison_NN ,_, 46_CD
          genes_NNS (_( over_IN four_CD times_NNS the_DT 10_CD expected_VBN by_IN chance_NN )_) were_VBD
          common_JJ to_TO the_DT 223_CD genes_NNS upregulated_JJ in_IN A_DT 549_CD cultures_NNS and_CC
          the_DT 256_CD genes_NNS upregulated_JJ in_IN U_NNP 118_CD cultures_NNS over_IN tumors_NNS (_( 
          p_NN <_NN 0_CD ._. 01_CD ,_, fold_VBP change_NN >_NN 2_LS )_) ._.
          Whereas_IN processes_NNS of_IN cell_NN division_NN and_CC metabolism_NN may_MD be_VB
          more_JJR in_IN common_JJ from_IN one_CD cancer_NN to_TO the_DT next_JJ ,_, processes_NNS of_IN
          cell_NN adhesion_NN and_CC ECM_NNP interaction_NN are_VBP likely_JJ to_TO be_VB very_RB
          different_JJ between_IN different_JJ cell_NN types_NNS ._. These_DT
          observations_NNS gave_VBD rise_NN to_TO the_DT hypothesis_NNS that_IN ,_, when_WRB
          placed_VBN in_IN comparable_JJ tissue_NN environments_NNS ,_, cancer_NN cells_NNS
          from_IN different_JJ lineages_NNS may_MD express_VB different_JJ cell_NN
          adhesion_NN and_CC ECM-related_NNP genes_NNS ._.
          To_TO test_VB our_PRP$ hypothesis_NNS that_IN A_DT 549_CD cells_NNS and_CC U_NNP 118_CD cells_NNS
          each_DT express_VB a_DT restricted_VBN set_NN of_IN ECM-related_NNP genes_NNS in_IN
          tumors_NNS ,_, we_PRP built_VBD a_DT classifier_NN for_IN distinguishing_VBG between_IN
          A_DT 549_CD and_CC U_NNP 118_CD cell-culture_JJ profiles_NNS ._. We_PRP used_VBD as_IN the_DT
          training_NN dataset_NN the_DT A_DT 549_CD and_CC U_NNP 118_CD tumor_NN profiles_NNS with_IN
          the_DT expression_NN values_NNS for_IN the_DT 30_CD genes_NNS that_WDT had_VBD both_DT an_DT
          association_NN in_IN the_DT literature_NN with_IN the_DT MeSH_NNP term_NN
          '_'' Extracellular_NNP matrix_NN proteins_NNS '_POS and_CC were_VBD significantly_RB
          upregulated_JJ (_( 
          p_NN <_NN 0_CD ._. 01_CD ,_, fold_VBP change_NN >_NN 2_LS )_)
          either_CC in_IN A_DT 549_CD xenograft_NN tumors_NNS over_IN cultures_NNS or_CC in_IN U_NNP 118_CD
          tumors_NNS over_IN cultures_NNS ._. We_PRP then_RB tested_VBD the_DT classifier_NN on_IN
          the_DT six_CD profiles_NNS from_IN A_DT 549_CD and_CC U_NNP 118_CD cell_NN cultures_NNS ._. The_DT
          classifier_NN distinguished_VBD perfectly_RB between_IN A_DT 549_CD and_CC U_NNP 118_CD
          profiles_NNS ,_, which_WDT indicates_VBZ that_IN the_DT expression_NN pattern_NN of_IN
          ECM-related_NNP genes_NNS upregulated_JJ in_IN the_DT A_DT 549_CD tumors_NNS is_VBZ more_RBR
          similar_JJ to_TO the_DT expression_NN pattern_NN of_IN the_DT same_JJ genes_NNS in_IN
          the_DT A_DT 549_CD cell_NN cultures_NNS than_IN it_PRP is_VBZ to_TO the_DT expression_NN of_IN
          these_DT genes_NNS in_IN the_DT U_NNP 118_CD cell_NN cultures_NNS ,_, and_CC vice_NN versa_RB ._. We_PRP
          built_VBD three_CD other_JJ similar_JJ classifiers_NNS :_: one_CD used_VBD the_DT
          expression_NN values_NNS of_IN the_DT 47_CD genes_NNS that_WDT are_VBP significantly_RB
          higher_JJR in_IN either_DT A_DT 549_CD or_CC U_NNP 118_CD tumors_NNS and_CC had_VBD an_DT
          association_NN with_IN the_DT MeSH_NNP term_NN '_'' Cell_NNP adhesion_NN '_'' ;_: the_DT
          second_RB used_VBD the_DT values_NNS for_IN 95_CD genes_NNS associated_VBN with_IN '_POS Cell_NNP
          differentiation_NN '_'' ;_: and_CC the_DT third_JJ used_VBD the_DT expression_NN
          values_NNS of_IN all_DT 236_CD genes_NNS higher_JJR in_IN A_DT 549_CD or_CC U_NNP 118_CD tumors_NNS
          with_IN 
          p_NN less_JJR than_IN 0_CD ._. 01_CD and_CC fold_VB change_NN
          greater_JJR than_IN two_CD ._. All_DT three_CD classifiers_NNS correctly_RB
          distinguished_VBD between_IN A_DT 549_CD and_CC U_NNP 118_CD cell_NN cultures_NNS ._. Figure_NN
          2_CD shows_VBZ a_DT cluster_NN diagram_NN of_IN the_DT expression_NN signatures_NNS of_IN
          the_DT 47_CD cell_NN adhesion-related_JJ genes_NNS across_IN all_DT profiles_NNS ,_,
          showing_VBG most_JJS of_IN the_DT genes_NNS as_IN appearing_VBG more_RBR highly_RB
          expressed_VBD in_IN either_DT the_DT A_DT 549_CD tumors_NNS or_CC the_DT U_NNP 118_CD tumors_NNS ,_,
          but_CC not_RB in_IN both_DT ._.
        
      
      
        Discussion_NNP
        Cells_NNP grown_VBN in_IN culture_NN have_VBP unlimited_JJ access_NN to_TO
        nutrients_NNS under_IN conditions_NNS most_RBS favorable_JJ for_IN growth_NN and_CC
        proliferation_NN and_CC little_JJ exposure_NN to_TO extrinsic_JJ factors_NNS such_JJ
        as_IN cytokines_NNS that_WDT modulate_VBP growth_NN and_CC differentiation_NN ._. In_IN
        contrast_NN ,_, cells_NNS in_IN a_DT tumor_NN growing_VBG in_IN a_DT host_NN tissue_NN
        environment_NN face_NN conditions_NNS with_IN more_RBR limited_JJ nutrients_NNS and_CC
        oxygen_NN and_CC are_VBP subjected_VBN to_TO or_CC benefit_NN from_IN a_DT wide_JJ variety_NN
        of_IN host_NN factors_NNS ._. The_DT ability_NN of_IN cancer_NN cells_NNS to_TO proliferate_VBP
        within_IN a_DT tissue_NN depends_VBZ on_IN their_PRP$ response_NN to_TO adhesive_NN and_CC
        growth_NN factor_NN cues_NNS within_IN the_DT ECM_NNP [_NN 10_CD ]_NN ,_, and_CC
        self-sufficiency_JJ in_IN growth_NN signals_NNS is_VBZ one_CD of_IN the_DT hallmarks_NNS
        of_IN cancer_NN [_NN 11_CD ]_NN ._. To_TO stimulate_VB their_PRP$ own_JJ growth_NN and_CC
        proliferation_NN in_IN tissue_NN ,_, tumor_NN cells_NNS can_MD overproduce_NN and_CC
        release_VB their_PRP$ own_JJ growth_NN factors_NNS or_CC obtain_VB them_PRP from_IN the_DT
        matrix_NN as_IN they_PRP are_VBP released_VBN by_IN matrix_NN metalloproteinases_NNS [_NN
        12_CD ]_NN ._. The_DT endothelial_NN vasculature_NN grows_VBZ into_IN the_DT tumor_NN and_CC
        provides_VBZ nutrients_NNS and_CC oxygen_NN [_NN 13_CD ]_NN ._. This_DT model_NN is_VBZ
        illustrated_VBN by_IN the_DT experimental_JJ results_NNS presented_VBN here_RB ,_, as_IN
        both_DT A_DT 549_CD (_( lung_NN )_) and_CC U_NNP 118_CD (_( brain_NN )_) cell_NN lines_NNS are_VBP observed_VBN
        to_TO upregulate_NN one_CD set_NN of_IN genetic_JJ programs_NNS related_VBN to_TO cell_NN
        growth_NN and_CC proliferation_NN when_WRB in_IN culture_NN and_CC another_DT set_VBN
        related_VBN to_TO cell_NN adhesion_NN ,_, the_DT extracellular_NN matrix_NN ,_, growth_NN
        substances_NNS ,_, and_CC neovascularization_NN when_WRB developing_VBG as_IN an_DT 
        in_IN vivo_NN tumor_NN ._.
        In_IN terms_NNS of_IN new_JJ biological_JJ insight_NN into_IN cancer_NN
        development_NN ,_, our_PRP$ findings_NNS suggest_VBP that_IN cancer_NN cells_NNS of_IN
        different_JJ origins_NNS interact_NN in_IN different_JJ ways_NNS with_IN the_DT same_JJ
        extracellular_NN environment_NN to_TO survive_VB and_CC proliferate_VBP as_IN
        tumors_NNS ._. These_DT lineage-specific_JJ genetic_JJ programs_NNS for_IN cell_NN
        adhesion_NN and_CC ECM_NNP interaction_NN ,_, although_IN less_RBR active_JJ in_IN cell_NN
        culture_NN ,_, are_VBP not_RB lost_VBN ,_, but_CC may_MD be_VB reactivated_VBN when_WRB cells_NNS
        are_VBP transplanted_VBN back_RB into_IN an_DT 
        in_IN vivo_NN environment_NN ,_, even_RB if_IN the_DT new_JJ
        environment_NN is_VBZ different_JJ from_IN the_DT tissue_NN of_IN origin_NN of_IN the_DT
        cancer_NN ._. This_DT conclusion_NN is_VBZ based_VBN on_IN the_DT significant_JJ
        representation_NN of_IN genes_NNS associated_VBN with_IN cell_NN adhesion_NN and_CC
        the_DT ECM_NNP in_IN both_DT the_DT A_DT 549_CD and_CC the_DT U_NNP 118_CD xenograft_NN tumors_NNS ._.
        However_RB ,_, the_DT genes_NNS in_IN each_DT case_NN represent_VB two_CD very_RB distinct_JJ
        sets_NNS ,_, the_DT set_VBN in_IN the_DT U_NNP 118_CD tumors_NNS being_VBG more_RBR similar_JJ in_IN
        their_PRP$ expression_NN pattern_NN to_TO that_DT of_IN the_DT U_NNP 118_CD cell_NN cultures_NNS
        than_IN to_TO the_DT A_DT 549_CD cultures_NNS ,_, and_CC vice_NN versa_RB ._.
        Although_IN tumors_NNS are_VBP known_VBN to_TO express_VB high_JJ levels_NNS of_IN
        genes_NNS involved_VBN in_IN cell_NN adhesion_NN and_CC the_DT ECM_NNP ,_, as_IN we_PRP observed_VBD
        in_IN the_DT xenografts_NNS ,_, assessment_NN of_IN the_DT specific_JJ contribution_NN
        of_IN cancer_NN cells_NNS to_TO the_DT increased_VBN expression_NN may_MD be_VB
        difficult_JJ ._. In_IN the_DT case_NN of_IN human_JJ tumor_NN xenografts_NNS in_IN a_DT mouse_NN
        host_NN ,_, however_RB ,_, it_PRP can_MD be_VB determined_VBN conclusively_RB that_DT
        expression_NN of_IN cell_NN adhesion_NN and_CC ECM_NNP genes_NNS is_VBZ upregulated_JJ in_IN
        the_DT cancerous_JJ cells_NNS in_IN the_DT tumor_NN tissue_NN ._. This_DT conclusion_NN is_VBZ
        based_VBN on_IN the_DT following_VBG two_CD observations_NNS ._. First_LS ,_, profiling_VBG
        mouse_NN tissue_NN alone_RB using_VBG probe_NN sets_NNS designed_VBN for_IN human_JJ
        genes_NNS gives_VBZ poor_JJ hybridization_NN ,_, to_TO the_DT extent_NN that_IN the_DT
        contribution_NN from_IN mouse_NN genes_NNS would_MD not_RB have_VB been_VBN enough_RB to_TO
        account_VB for_IN the_DT differences_NNS in_IN gene_NN expression_NN observed_VBD ._.
        Second_JJ ,_, different_JJ cell_NN adhesion_NN and_CC ECM-related_NNP genes_NNS are_VBP
        upregulated_JJ in_IN tumors_NNS of_IN different_JJ cell_NN types_NNS (_( A_DT 549_CD versus_CC
        U_NNP 118_CD )_) ;_: if_IN the_DT upregulation_NN were_VBD due_JJ to_TO a_DT common_JJ mouse_NN
        source_NN ,_, then_RB the_DT same_JJ genes_NNS should_MD have_VB appeared_VBN
        upregulated_JJ in_IN both_DT cell_NN types_NNS ,_, given_VBN that_IN the_DT cells_NNS were_VBD
        grown_VBN in_IN the_DT same_JJ site_NN ._.
        The_DT findings_NNS presented_VBN here_RB ,_, suggesting_VBG that_IN different_JJ
        ECM_NNP signaling_VBG pathways_NNS are_VBP active_JJ in_IN different_JJ cancers_NNS ,_,
        could_MD have_VB important_JJ clinical_JJ implications_NNS ,_, as_IN knowledge_NN of_IN
        the_DT specific_JJ pathways_NNS dysregulated_JJ in_IN a_DT particular_JJ cancer_NN
        may_MD be_VB valuable_JJ for_IN devising_VBG effective_JJ therapy_NN that_IN targets_NNS
        those_DT pathways_NNS ._. As_IN candidates_NNS for_IN further_RBR investigation_NN ,_, we_PRP
        have_VBP identified_VBN genes_NNS that_WDT appear_VBP upregulated_JJ in_IN certain_JJ
        cancers_NNS 
        in_IN vivo_NN compared_VBN to_TO 
        in_IN vitro_NN and_CC that_WDT belong_VBP to_TO distinct_JJ
        functional_JJ classes_NNS related_VBN to_TO tumor_NN progression_NN ._. Also_RB of_IN
        interest_NN are_VBP genes_NNS that_WDT are_VBP upregulated_JJ in_IN both_DT the_DT
        cancers_NNS ,_, including_VBG 
        IGFBP_NNP 3_CD (_( insulin-like_JJ growth_NN factor_NN
        binding_JJ protein_NN 3_LS )_) ,_, which_WDT ,_, interestingly_RB ,_, is_VBZ thought_VBN to_TO
        have_VB proapoptotic_JJ activities_NNS [_NN 14_CD ]_NN ,_, and_CC 
        GSN_NNP (_( gelsolin_NN )_) ,_, which_WDT has_VBZ a_DT role_NN in_IN
        cellular_JJ motility_NN and_CC acts_NNS as_IN both_DT a_DT regulator_NN and_CC effector_NN
        of_IN apoptosis_NNS [_NN 15_CD ]_NN ._. Further_RB xenograft_NN studies_NNS of_IN the_DT type_NN
        presented_VBN here_RB could_MD examine_VB the_DT responses_NNS of_IN the_DT host_NN
        tissue_NN to_TO the_DT tumor_NN (_( using_VBG a_DT mouse_NN microarray_NN chip_NN )_) ,_, as_RB
        well_RB as_IN temporal_JJ changes_NNS in_IN gene_NN expression_NN within_IN the_DT
        developing_VBG tumor_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Cell_NNP lines_NNS and_CC tumors_NNS
          Both_DT the_DT A_DT 549_CD lung_NN adenocarcinoma_NN cell_NN line_NN and_CC the_DT
          U_NNP 118_CD brain_NN glioblastoma_NN cell_NN line_NN were_VBD cultured_JJ at_IN 37_CD °_NN C_NNP
          in_IN a_DT 6_CD %_NN CO_NNP 
          2_CD -_: humidified_JJ incubator_NN in_IN DMEM_NNP
          supplemented_JJ with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN ,_, 100_CD U_NNP /_NN ml_NN
          penicillin_NN and_CC 100_CD U_NNP /_NN ml_NN streptomycin_NN ._. The_DT cells_NNS were_VBD
          passaged_JJ weekly_NN upon_IN reaching_VBG confluence_NN ._. We_PRP produced_VBD
          tumors_NNS in_IN immunodeficient_NN SCID_NNP C_NNP ._. B-_NNP 17_CD mice_NNS by_IN inoculating_VBG
          5_CD ×_NN 10_CD 6_CD cells_NNS (_( either_CC A_DT 549_CD or_CC U_NNP 118_CD )_) subcutaneously_RB per_IN
          mouse_NN in_IN the_DT intrascapular_NN region_NN ._. Tumors_NNP greater_JJR than_IN 5_CD
          mm_NN in_IN diameter_NN (_( range_NN =_SYM 5_CD -_: 7_CD mm_NN )_) were_VBD observed_VBN within_IN 21_CD
          days_NNS in_IN all_PDT the_DT mice_NNS inoculated_JJ ._. The_DT tumors_NNS were_VBD
          harvested_VBN under_IN sterile_JJ conditions_NNS and_CC trimmed_VBD of_IN adipose_NN
          and_CC connective_JJ tissue_NN ._. Total_NNP RNA_NNP was_VBD prepared_VBN from_IN tumor_NN
          tissue_NN ._.
        
        
          Gene-expression_NNP profiling_VBG
          Three_CD A_DT 549_CD xenograft_NN tumors_NNS obtained_VBN from_IN different_JJ
          mice_NNS ,_, three_CD U_NNP 118_CD tumors_NNS from_IN different_JJ mice_NNS ,_, three_CD A_DT 549_CD
          cell-culture_JJ samples_NNS ,_, and_CC three_CD U_NNP 118_CD culture_NN samples_NNS were_VBD
          each_DT profiled_VBN using_VBG HuGeneFL_NNP microarray_NN chips_NNS
          (_( Affymetrix_NNP ,_, Santa_NNP Clara_NNP ,_, CA_NNP )_) ,_, which_WDT consist_VBP of_IN 7_CD ,_, 069_CD
          probe_NN sets_NNS ,_, each_DT representing_VBG an_DT mRNA_NN transcript_NN ._. To_TO
          assess_VB the_DT amount_NN of_IN hybridization_NN with_IN the_DT HuGeneFL_NNP chip_NN
          (_( designed_VBN for_IN human_JJ mRNAs_NNS )_) that_WDT could_MD be_VB attributable_JJ to_TO
          mouse_NN mRNA_NN in_IN a_DT xenograft_NN tumor_NN sample_NN ,_, a_DT sample_NN of_IN mouse_NN
          lung_NN tissue_NN was_VBD also_RB profiled_VBN ._. Preparation_NNP of_IN mRNA_NN ,_,
          hybridization_NN of_IN the_DT arrays_NNS ,_, and_CC computation_NN of_IN probe-set_JJ
          intensities_NNS were_VBD as_RB previously_RB described_VBD [_NN 5_CD 16_CD 17_CD ]_NN ._.
          The_DT exogenous_JJ probe_NN set_VBD controls_NNS on_IN the_DT HuGeneFL_NNP chip_NN
          (_( probe_NN sets_NNS that_WDT give_VBP constant_JJ hybridization_NN from_IN sample_NN
          to_TO sample_NN )_) were_VBD used_VBN to_TO determine_VB scaling_VBG factors_NNS for_IN
          comparing_VBG the_DT mouse_NN lung_NN profile_NN with_IN the_DT xenograft_NN and_CC
          culture_NN profiles_NNS ._. For_IN each_DT probe_NN set_VBD ,_, we_PRP computed_JJ the_DT
          fold_VB changes_NNS for_IN human_JJ cell-line_JJ cultures_NNS (_( U_NNP 118_CD and_CC A_DT 549_CD )_)
          with_IN 20_CD %_NN mouse_NN lung_NN compared_VBN to_TO the_DT pure_JJ cell_NN line_NN ,_, using_VBG
          the_DT expression_NN (_( 0_CD ._. 8_CD ×_NN [_NN human_JJ ]_NN +_NN 0_CD ._. 2_CD ×_NN [_NN mouse_NN ]_NN )_) /_NN [_NN human_JJ ]_NN ._.
          This_DT assessed_VBD the_DT potential_JJ impact_NN of_IN mouse_NN tissue_NN on_IN
          differences_NNS observed_VBD between_IN xenograft_NN tumor_NN and_CC
          cell-culture_JJ profiles_NNS ._.
          As_IN criteria_NNS for_IN determining_VBG significant_JJ differences_NNS in_IN
          mean_NN gene_NN mRNA_NN expression_NN levels_NNS between_IN groups_NNS of_IN
          samples_NNS ,_, we_PRP used_VBD both_DT a_DT 
          p_NN -_: value_NN less_JJR than_IN 0_CD ._. 01_CD using_VBG the_DT
          two-sample_JJ 
          t_NN -_: test_NN and_CC a_DT fold_VB change_NN greater_JJR
          than_IN two_CD either_DT way_NN ._. Probe-set_NNP intensities_NNS less_JJR than_IN 50_CD
          were_VBD set_VBN to_TO 50_CD ._. Permutation_NNP testing_NN was_VBD used_VBN to_TO assess_VB
          the_DT number_NN of_IN genes_NNS that_WDT could_MD be_VB considered_VBN significant_JJ
          for_IN any_DT arbitrary_JJ separation_NN of_IN the_DT profiles_NNS into_IN two_CD
          groups_NNS ._. Hierarchical_NNP clustering_VBG ,_, using_VBG the_DT Eisen_NNP software_NN
          [_NN 18_CD 19_CD ]_NN ,_, was_VBD applied_VBN using_VBG the_DT average_JJ linkage_NN method_NN
          as_IN an_DT aid_NN to_TO visualizing_VBG gene-expression_JJ patterns_NNS of_IN
          interest_NN ._. Global_JJ views_NNS of_IN the_DT variation_NN in_IN gene_NN
          expression_NN among_IN cell_NN specimens_NNS were_VBD obtained_VBN using_VBG PCA_NNP [_NN
          17_CD ]_NN ._.
        
        
          Significantly_RB enriched_JJ classes_NNS within_IN gene_NN
          sets_NNS
          For_IN a_DT given_VBN set_NN of_IN genes_NNS showing_VBG significant_JJ
          differences_NNS in_IN expression_NN between_IN comparison_NN groups_NNS ,_, a_DT
          search_NN was_VBD made_VBN within_IN the_DT set_VBN for_IN '_POS significantly_RB
          enriched_JJ '_POS functional_JJ classes_NNS of_IN genes_NNS ,_, as_IN described_VBN
          previously_RB [_NN 20_CD ]_NN ._. For_IN the_DT entire_JJ set_NN of_IN genes_NNS profiled_VBN
          on_IN the_DT HuGeneFL_NNP chip_NN ,_, each_DT gene_NN was_VBD grouped_VBN into_IN one_CD or_CC
          more_JJR classes_NNS as_IN defined_VBN by_IN one_CD of_IN the_DT following_JJ criteria_NNS :_:
          a_DT common_JJ Gene_NNP Ontology_NNP (_( GO_NNP )_) annotation_NN term_NN ,_, where_WRB on_IN the_DT
          order_NN of_IN 1_CD ,_, 000_CD terms_NNS were_VBD considered_VBN [_NN 21_CD ]_NN ;_: and_CC a_DT
          common_JJ MeSH_NNP literature_NN term_NN [_NN 22_CD ]_NN association_NN as_IN defined_VBN
          below_IN ._. GO_NNP term_NN gene_NN assignments_NNS related_VBN to_TO categories_NNS of_IN
          '_POS biological_JJ process_NN '_'' or_CC '_POS molecular_JJ function_NN '_'' were_VBD
          obtained_VBN from_IN LocusLink_NNP [_NN 23_CD 24_CD ]_NN and_CC the_DT GO_NNP term_NN
          hierarchy_NN was_VBD obtained_VBN from_IN the_DT Gene_NNP Ontology_NNP Consortium_NNP
          [_NN 25_CD ]_NN ._. For_IN each_DT GO_NNP term_NN assigned_VBN to_TO a_DT given_VBN gene_NN in_IN
          LocusLink_NNP ,_, we_PRP also_RB assigned_VBN all_DT hierarchical_JJ parent_NN terms_NNS
          of_IN the_DT term_NN to_TO the_DT gene_NN ._.
          For_IN each_DT gene_NN profiled_VBN in_IN the_DT study_NN ,_, the_DT summaries_NNS of_IN
          the_DT 50_CD most_RBS recent_JJ articles_NNS that_WDT mention_VBP the_DT gene_NN by_IN any_DT
          one_CD of_IN its_PRP$ common_JJ aliases_NNS in_IN the_DT article_NN abstract_JJ were_VBD
          downloaded_JJ from_IN the_DT web_NN ,_, using_VBG the_DT Entrez_NNP utilities_NNS
          (_( described_VBD at_IN [_NN 26_CD ]_NN )_) ._. An_DT association_NN was_VBD then_RB made_VBN
          between_IN the_DT gene_NN and_CC any_DT MeSH_NNP index_NN terms_NNS included_VBD within_IN
          those_DT summaries_NNS ._. To_TO reduce_VB search_NN time_NN and_CC spurious_JJ or_CC
          uninteresting_VBG results_NNS ,_, before_IN searching_VBG for_IN common_JJ MeSH_NNP
          term_NN associations_NNS we_PRP first_RB reviewed_VBD the_DT MeSH_NNP terms_NNS
          downloaded_JJ for_IN the_DT entire_JJ set_NN of_IN genes_NNS profiled_VBN ._. We_PRP
          removed_VBD from_IN further_JJ consideration_NN any_DT MeSH_NNP term_NN that_WDT
          appeared_VBD to_TO have_VB no_DT relevance_NN to_TO our_PRP$ study_NN (_( for_IN example_NN ,_,
          MeSH_NNP terms_NNS describing_VBG experimental_JJ protocols_NNS or_CC the_DT
          healthcare_NN system_NN )_) ._. MeSH_NNP terms_NNS that_WDT were_VBD associated_VBN with_IN
          fewer_JJR than_IN 20_CD genes_NNS were_VBD also_RB discarded_VBN ,_, leaving_VBG some_DT
          4_CD ,_, 000_CD MeSH_NNP terms_NNS that_WDT were_VBD considered_VBN in_IN the_DT analysis_NN ._.
          Similarly_RB ,_, GO_NNP gene_NN classes_NNS that_WDT applied_VBD to_TO less_JJR than_IN four_CD
          of_IN the_DT genes_NNS under_IN study_NN were_VBD not_RB considered_VBN ._.
          For_IN a_DT given_VBN set_NN of_IN 
          k_NN significant_JJ genes_NNS ,_, two_CD separate_JJ
          searches_NNS were_VBD made_VBN for_IN enriched_JJ GO_NNP term_NN classes_NNS and_CC MeSH_NNP
          term_NN classes_NNS ._. For_IN a_DT given_VBN gene_NN class_NN common_JJ to_TO 
          n_NN genes_NNS within_IN the_DT 
          k_NN set_VBD ,_, where_WRB the_DT class_NN applied_VBN to_TO a_DT
          total_NN of_IN 
          A_DT genes_NNS out_IN of_IN the_DT entire_JJ set_NN of_IN 
          G_NNP unique_JJ genes_NNS under_IN study_NN ,_, the_DT
          probability_NN ,_, 
          p_NN ,_, for_IN the_DT term_NN occurring_VBG 
          n_NN or_CC more_JJR times_NNS within_IN a_DT set_NN of_IN 
          k_NN genes_NNS randomly_RB selected_VBN from_IN the_DT
          chip_NN was_VBD calculated_VBN using_VBG the_DT one-sided_JJ Fisher_NNP 's_POS exact_JJ
          test_NN ._. As_IN multiple_JJ gene_NN classes_NNS were_VBD tested_VBN for_IN our_PRP$ set_NN of_IN
          genes_NNS of_IN interest_NN ,_, the_DT true_JJ significance_NN of_IN a_DT low_JJ 
          p_NN -_: value_NN for_IN an_DT enriched_JJ class_NN was_VBD
          estimated_VBN using_VBG 100_CD separate_JJ Monte_NNP Carlo_NNP simulation_NN
          tests_NNS ._. For_IN each_DT test_NN 
          k_NN genes_NNS were_VBD first_JJ randomly_RB
          selected_VBN from_IN the_DT set_NN of_IN 
          G_NNP genes_NNS ,_, and_CC 
          p_NN -_: values_NNS for_IN the_DT classes_NNS occurring_VBG
          within_IN the_DT 
          k_NN set_NN of_IN genes_NNS were_VBD then_RB
          calculated_VBN ._. For_IN a_DT 
          p_NN -_: value_NN for_IN a_DT given_VBN class_NN found_VBD in_IN
          the_DT original_JJ 
          k_NN set_NN of_IN genes_NNS ,_, we_PRP calculated_VBD the_DT
          number_NN of_IN classes_NNS that_WDT could_MD be_VB expected_VBN to_TO have_VB a_DT 
          p_NN -_: value_NN as_IN low_JJ or_CC lower_JJR in_IN a_DT set_NN
          of_IN 
          k_NN randomly_RB selected_VBD genes_NNS ,_, based_VBN on_IN
          the_DT simulation_NN results_NNS ._. For_IN each_DT class_NN found_VBD to_TO be_VB
          represented_VBN in_IN two_CD given_VBN sets_NNS ,_, one_CD with_IN 
          k_NN genes_NNS and_CC the_DT other_JJ with_IN 
          l_NN genes_NNS ,_, with_IN 
          p_NN -_: values_NNS less_JJR than_IN 0_CD ._. 05_CD in_IN both_DT
          cases_NNS ,_, we_PRP calculated_VBD on_IN the_DT basis_NN of_IN simulation_NN results_VBZ
          the_DT number_NN of_IN classes_NNS expected_VBN to_TO be_VB found_VBN in_IN both_DT a_DT
          random_JJ 
          k-_NN gene_NN set_VBN and_CC a_DT random_JJ 
          l_NN -_: gene_NN set_VBN with_IN 
          p_NN -_: values_NNS less_JJR than_IN 0_CD ._. 05_CD in_IN both_DT ._.
          In_IN this_DT case_NN ,_, we_PRP carried_VBD out_IN 100_CD simulation_NN tests_NNS ,_, in_IN
          each_DT of_IN which_WDT one_CD set_NN of_IN 
          k_NN genes_NNS and_CC another_DT set_NN of_IN 
          l_NN genes_NNS were_VBD each_DT randomly_RB selected_VBN
          from_IN the_DT entire_JJ set_NN of_IN 
          G_NNP genes_NNS under_IN study_NN ._. For_IN each_DT gene_NN
          class_NN that_WDT was_VBD found_VBN to_TO be_VB represented_VBN in_IN both_DT random_JJ
          gene_NN sets_NNS ,_, 
          p_NN -_: values_NNS for_IN enrichment_NN were_VBD
          calculated_VBN for_IN each_DT of_IN the_DT two_CD sets_NNS ._.
        
        
          Classification_NNP of_IN cell-line_JJ lineage_NN based_VBN on_IN gene_NN
          expression_NN
          In_IN order_NN to_TO determine_VB whether_IN the_DT lineage_NN ,_, A_DT 549_CD or_CC
          U_NNP 118_CD ,_, of_IN a_DT given_VBN cell_NN population_NN could_MD be_VB predicted_VBN on_IN
          the_DT basis_NN of_IN its_PRP$ gene-expression_JJ profile_NN ,_, we_PRP built_VBD a_DT
          classifier_NN using_VBG a_DT training_NN set_NN of_IN profiles_NNS with_IN a_DT set_NN of_IN
          genes_NNS of_IN interest_NN to_TO be_VB used_VBN as_IN markers_NNS ._. To_TO classify_VB a_DT
          test_NN sample_NN as_IN either_DT A_DT 549_CD or_CC U_NNP 118_CD ,_, we_PRP computed_JJ the_DT
          correlation_NN coefficient_NN between_IN the_DT expression_NN values_NNS of_IN
          the_DT markers_NNS in_IN the_DT test_NN sample_NN profile_NN and_CC the_DT same_JJ genes_NNS
          on_IN each_DT of_IN the_DT profiles_NNS in_IN the_DT training_NN set_VBN (_( using_VBG
          log-transformed_JJ values_NNS )_) ._. The_DT class_NN identity_NN of_IN the_DT
          majority_NN of_IN the_DT top_JJ five_CD training_NN profiles_NNS having_VBG the_DT
          greatest_JJS correlation_NN with_IN the_DT test_NN profile_NN was_VBD then_RB
          assigned_VBN to_TO that_DT profile_NN ._. This_DT strategy_NN is_VBZ known_VBN in_IN the_DT
          classification_NN literature_NN as_IN "_'' five-nearest_JJ neighbors_NNS with_IN
          majority_NN voting_NN "_'' [_NN 16_CD ]_NN ._.
        
      
      
        Additional_JJ data_NNS files_NNS
        The_DT following_VBG files_NNS are_VBP available_JJ with_IN the_DT online_NN
        version_NN of_IN this_DT article_NN :_: expression_NN datasets_NNS of_IN the_DT cell_NN
        culture_NN and_CC xenograft_NN profiles_NNS as_IN a_DT tab-delimited_JJ text_NN file_NN
        (_( Additional_JJ data_NNS file_VBP 1_LS )_) ;_: a_DT spreadsheet_NN file_NN including_VBG
        extra_JJ data_NNS ,_, such_JJ as_IN the_DT scale-normalized_JJ means_VBZ prior_RB to_TO
        quantile_NN normalization_NN ,_, 
        p_NN -_: values_NNS from_IN the_NNP '_POS present_JJ '_POS test_NN ,_, a_DT
        sheet_NN of_IN data_NNS from_IN 60_CD control_NN probe-sets_JJ on_IN the_DT Affymetrix_NNP
        chips_NNS ,_, and_CC data_NNS from_IN the_DT mouse_NN lung_NN tissue_NN control_NN profile_NN
        (_( Additional_JJ data_NNS file_VBP 2_LS )_) ;_: the_DT search_NN results_NNS for_IN
        significantly_RB enriched_JJ classes_NNS for_IN GO_NNP annotation_NN
        (_( Additional_JJ data_NNS file_VBP 3_LS )_) and_CC for_IN MeSH_NNP term_NN literature_NN
        associations_NNS (_( Additional_JJ data_NNS file_VBP 4_LS )_) for_IN genes_NNS found_VBD to_TO
        significantly_RB differ_VB at_IN 
        p_NN <_NN 0_CD ._. 01_CD ,_, fold_VBP change_NN >_NN 2_CD
        between_IN tumors_NNS and_CC cell_NN cultures_NNS for_IN a_DT given_VBN cell_NN line_NN ;_: the_DT
        values_NNS used_VBN in_IN the_DT classifications_NNS of_IN cell_NN culture_NN lineage_NN
        using_VBG xenograft_NN tumor_NN profiles_NNS ,_, together_RB with_IN the_DT
        classification_NN results_NNS ,_, which_WDT correctly_RB predicted_VBD the_DT
        lineage_NN of_IN all_DT six_CD cell_NN culture_NN profiles_NNS ,_, as_IN an_DT Excel_NNP
        spreadsheet_NN (_( Additional_JJ data_NNS file_VBP 5_LS )_) ._. The_DT software_NN for_IN
        finding_VBG significantly_RB enriched_JJ classes_NNS within_IN gene_NN sets_NNS is_VBZ
        available_JJ from_IN the_DT authors_NNS '_POS website_NN [_NN 7_CD ]_NN ._.
        Additional_JJ data_NNS file_VBP 1_CD
        Expression_NNP datasets_NNS of_IN the_DT cell_NN culture_NN and_CC xenograft_NN
        profiles_NNS
        Expression_NNP datasets_NNS of_IN the_DT cell_NN culture_NN and_CC xenograft_NN
        profiles_NNS
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 2_CD
        The_DT scale-normalized_JJ means_VBZ prior_RB to_TO quantile_NN
        normalization_NN ,_, 
        p_NN -_: values_NNS from_IN the_NNP '_POS present_JJ '_POS test_NN ,_, a_DT
        sheet_NN of_IN data_NNS from_IN 60_CD control_NN probe-sets_JJ on_IN the_DT Affymetrix_NNP
        chips_NNS ,_, and_CC data_NNS from_IN the_DT mouse_NN lung_NN tissue_NN control_NN
        profile_NN
        The_DT scale-normalized_JJ means_VBZ prior_RB to_TO quantile_NN
        normalization_NN ,_, 
        p_NN -_: values_NNS from_IN the_NNP '_POS present_JJ '_POS test_NN ,_, a_DT
        sheet_NN of_IN data_NNS from_IN 60_CD control_NN probe-sets_JJ on_IN the_DT Affymetrix_NNP
        chips_NNS ,_, and_CC data_NNS from_IN the_DT mouse_NN lung_NN tissue_NN control_NN
        profile_NN
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 3_CD
        The_DT search_NN results_NNS for_IN significantly_RB enriched_JJ classes_NNS
        for_IN GO_NNP annotation_NN for_IN genes_NNS found_VBD to_TO significantly_RB differ_VB
        between_IN tumors_NNS and_CC cell_NN cultures_NNS for_IN a_DT given_VBN cell_NN line_NN
        The_DT search_NN results_NNS for_IN significantly_RB enriched_JJ classes_NNS
        for_IN GO_NNP annotation_NN for_IN genes_NNS found_VBD to_TO significantly_RB differ_VB
        between_IN tumors_NNS and_CC cell_NN cultures_NNS for_IN a_DT given_VBN cell_NN line_NN
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 4_CD
        The_DT search_NN results_NNS for_IN significantly_RB enriched_JJ classes_NNS
        for_IN MeSH_NNP term_NN literature_NN associations_NNS for_IN genes_NNS found_VBD to_TO
        significantly_RB differ_VB between_IN tumors_NNS and_CC cell_NN cultures_NNS for_IN a_DT
        given_VBN cell_NN line_NN
        The_DT search_NN results_NNS for_IN significantly_RB enriched_JJ classes_NNS
        for_IN MeSH_NNP term_NN literature_NN associations_NNS for_IN genes_NNS found_VBD to_TO
        significantly_RB differ_VB between_IN tumors_NNS and_CC cell_NN cultures_NNS for_IN a_DT
        given_VBN cell_NN line_NN
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 5_CD
        The_DT values_NNS used_VBN in_IN the_DT classifications_NNS of_IN cell_NN culture_NN
        lineage_NN using_VBG xenograft_NN tumor_NN profiles_NNS ,_, together_RB with_IN the_DT
        classification_NN results_NNS ,_, which_WDT correctly_RB predicted_VBD the_DT
        lineage_NN of_IN all_DT six_CD cell_NN culture_NN profiles_NNS
        The_DT values_NNS used_VBN in_IN the_DT classifications_NNS of_IN cell_NN culture_NN
        lineage_NN using_VBG xenograft_NN tumor_NN profiles_NNS ,_, together_RB with_IN the_DT
        classification_NN results_NNS ,_, which_WDT correctly_RB predicted_VBD the_DT
        lineage_NN of_IN all_DT six_CD cell_NN culture_NN profiles_NNS
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
      
    
  
